Cargando…

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

INTRODUCTION: The implementation of small-molecule and immunotherapies in acute myeloid leukemia (AML) has been challenging due to genetic and epigenetic variability amongst patients. There are many potential mechanisms by which immune cells could influence small-molecule or immunotherapy responses,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romine, Kyle A., Bottomly, Daniel, Yashar, William, Long, Nicola, Viehdorfer, Matthew, McWeeney, Shannon K., Tyner, Jeffrey W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285384/ https://www.ncbi.nlm.nih.gov/pubmed/37361575 http://dx.doi.org/10.3389/fonc.2023.1192829

Ejemplares similares

A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
por: Damnernsawad, Alisa, et al.
Publicado: (2020)

Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
por: Kurtz, Stephen E., et al.
Publicado: (2022)

Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia
por: Rice, William G., et al.
Publicado: (2022)

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

plethy: management of whole body plethysmography data in R
por: Bottomly, Daniel, et al.
Publicado: (2015)

HitWalker2: visual analytics for precision medicine and beyond
por: Bottomly, Daniel, et al.
Publicado: (2016)

ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
por: Joshi, Sunil K., et al.
Publicado: (2020)

HitWalker: variant prioritization for personalized functional cancer genomics
por: Bottomly, Daniel, et al.
Publicado: (2013)

Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq
por: Bottomly, Daniel, et al.
Publicado: (2010)

Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy
por: Zhang, Yi, et al.
Publicado: (2022)

Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine
por: Bottomly, Daniel, et al.
Publicado: (2013)

Detection of Expression Quantitative Trait Loci in Complex Mouse Crosses: Impact and Alleviation of Data Quality and Complex Population Substructure
por: Iancu, Ovidiu D., et al.
Publicado: (2012)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia
por: O'Connor, David, et al.
Publicado: (2023)

Comprehensive molecular characterization of a rare case of Philadelphia chromosome–positive acute myeloid leukemia
por: Rosenberg, Mara W., et al.
Publicado: (2022)

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms
por: Zhang, Haijiao, et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States
por: Smyth, Emily Nash, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia
por: Khanna, Vishesh, et al.
Publicado: (2015)

A patient-driven clinicogenomic partnership for metastatic prostate cancer
por: Crowdis, Jett, et al.
Publicado: (2022)

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia
por: Lamble, Adam J., et al.
Publicado: (2020)

A Single-Cell Approach to the Elusive Latent Human Cytomegalovirus Transcriptome
por: Goodrum, Felicia, et al.
Publicado: (2018)

Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms
por: Ruhnke, Leo, et al.
Publicado: (2021)

Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib
por: Vigoda, Myles, et al.
Publicado: (2022)

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia
por: Wiatrowski, Kyle, et al.
Publicado: (2022)

An Idealized Clinicogenomic Registry to Engage Underrepresented Populations Using Innovative Technology
por: Silva, Patrick, et al.
Publicado: (2022)

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study
por: Kemps, Paul G., et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
por: Thieme, Elana, et al.
Publicado: (2022)

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
por: Gao, Lina, et al.
Publicado: (2013)

The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traits
por: Hitzemann, Robert, et al.
Publicado: (2013)

In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview
por: Li, Zhiqin, et al.
Publicado: (2021)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia
por: Megías-Vericat, Juan Eduardo, et al.
Publicado: (2019)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
por: Suzuki, Tomotaka, et al.
Publicado: (2023)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Management of Chronic Myeloid Leukemia in Advanced Phase
por: Bonifacio, Massimiliano, et al.
Publicado: (2019)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
por: Récher, Christian
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7jfqvnupk6g4s2edis3qgprl4v